Discovery of first-in-class precision antibody drug conjugates with a potent SMARCA2/4 dual degrader payload 

Carter J, Agarwal A, Sivakumar M, Reichelderfer A, Park J, Osinubi O, Holmes R, Fultang N, Schwab A, Rager J, Stahl N, Cote J, Crossan A, Chen C, Pawley S, Wang M, Geeganage S, Lee S, Combs A, Scherle P, Buesking A and Ito K